HCPCS Level IIdrugActive
J9333
Inj rozanolixizum-noli 1 mg
BETOS: O1D
Effective: 2025-10-01
Description
Injection, rozanolixizumab-noli, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rystiggo
Manufacturer
UCB, Inc.
HCPCS Dosage
1 MG
Billing Units
280.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.